CompletedNot Applicable

Music Therapy Experiences in Patients With Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)

United States100 participantsStarted 2019-08-27

Plain-language summary

This study compares different music therapy (MT) experiences and their impact on memory and language in patients with Alzheimer's disease and Mild Cognitive Impairment. The 12-month study will assess the role of common experiences involving familiar music and other pleasant events (blinded control) to benefit cognition and measure the quality of life for people with Alzheimer's disease and Mild Cognitive Impairment. Following screening, all participants will meet with a licensed music therapist at the first study visit. Thereafter, each group will have an individualized schedule of follow-up telephone calls and visits. Screening for the study and participation in the study intervention can be completed in-person or from your home, if you do not live in the area.

Who can participate

Age range55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Alzheimer's disease or mild cognitive impairment * Must have study partner * English speaking * No verbal impairment * Community-dwelling * Must have webcam or smart phone Exclusion Criteria: * A diagnosis of dementia other than probable or possible AD * Probable AD with Down syndrome * History of a clinically significant stroke with residual deficit * Current evidence or history in past two years of epilepsy, focal brain lesion, head injury * Current diagnosis for major psychiatric disorder including psychosis, major depression, bipolar disorder, alcohol or substance abuse. * Participation in another interventional study * Comorbidity causing disability interfering with intervention such as pain or discomfort or life expectancy less than 1 year

What they're measuring

Mini Mental Status Exam (MMSE)

Timeframe: 12 months

Neuropsychiatric Inventory (NPI)

Timeframe: 12 months

Activities of Daily Living (ADCS-ADL)

Timeframe: 12 months

Clinician's Global Impression of Change (ADCS-CGIC)

Timeframe: 12 months

Trial details

NCT IDNCT04666077

SponsorIcahn School of Medicine at Mount Sinai

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07-15

View on ClinicalTrials.gov More Alzheimer's Disease trials

Plain-language summary

Who can participate

Age range55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.